How researchers are using AI to speed up drug discovery and development: Q&A
Drug development is among the slowest, most failure-prone processes in modern science, with about 90% of drug candidates never reaching the market. Today, artificial intelligence methods have accelerated the first step—plucking promising molecules out of endless...
What to take away
Watch whether this bright step keeps creating real value over time.
Why it's good
It shows curiosity and learning turning into real-world exploration.
Keep reading
More Bright Stories
Science and HealthA Million-Panel Project
Utah’s new solar power and battery storage facility is among the largest in the region.
NASA News - Jul 24
Science and HealthHow an iceberg may have stopped emperor penguins from breeding on Coulman Island in 2025
The number of chicks in the Coulman Island emperor penguin colony decreased by about 69% in 2025 compared with 2024, according to research published in Communications Earth & Environment. The authors suggest that a large iceberg, which grounded off the island between July 2025 and January 2026, likely restricted the colony's access to important foraging areas, demonstrating that individual iceberg movements may affect breeding success even when overall sea ice conditions appear favorable.
Phys.org Biology - Jul 24
Science and Health3D-printed bioplastic pods offer new hope for seagrass restoration in Thailand
A new collaborative research project between Murdoch University and Walailak University (WU) aims to restore seagrass meadows in Thailand using 3D-printed pods made from bioplastics.
Phys.org Biology - Jul 24
%2Fhttps%3A%2F%2Ftf-cmsv2-smithsonianmag-media.s3.amazonaws.com%2Ffiler_public%2Fc1%2Fa2%2Fc1a2a82f-5e62-4728-a670-4816f111957b%2Fbeta-amyloid_plaques_and_tau_in_the_brain_38686503251.png&w=1536&q=72&dpl=dpl_GAVGtBfYf7VbTphHxNZxt8PA1ST2)
Science and HealthExperimental Alzheimer's Drug That Fights a Tough-to-Target Protein Shows Promise at Slowing Cognitive Decline in a Clinical Trial
Recently FDA-approved treatments work to clear clumps of the protein amyloid beta in the brain. A drug that instead goes after tangles of the protein tau can yield similar cognitive outcomes, a new study suggests
Smithsonian Smart News - Jul 23